Isolated IgA anti- β 2 Glycoprotein i antibodies in patients with clinical criteria for antiphospholipid syndrome

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Ruiz García, Raquel ^a   Serrano, Manuel ^a   Ángel Martínez Flores, José ^a   Mora, Sergio ^a   Morillas, Luis ^a   Martín Mola, María Ángeles ^a   Morales, José M ^a   Paz Artal, Estela ^a,b   Serrano, Antonio ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CHORIONIC GONADOTROPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN A;

ADULT; ANTIBODY DETECTION; ANTIBODY ISOLATION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOCYSTINURIA; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREGNANCY DISORDER; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VEIN THROMBOSIS; ANTAGONISTS AND INHIBITORS; BLOOD; CAROTID ARTERY THROMBOSIS; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CAROTID ARTERY THROMBOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; VENOUS THROMBOSIS;

EID: 84899554236     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/704395     Document Type: Article

References (38)

1. Triplett D. A., Antiphospholipid antibodies. Archives of Pathology and Laboratory Medicine 2002 126 11 1424 1429 2-s2.0-0036881080
2. Fischer M. J., Rauch J., Levine J. S., The antiphospholipid syndrome. Seminars in Nephrology 2007 27 1 35 46 2-s2.0-33847271684 10.1016/j.semnephrol. 2006.09.006
3. Willis R., Harris E. N., Pierangeli S. S., Pathogenesis of the antiphospholipid syndrome. Seminars in Thrombosis and Hemostasis 2012 38 4 305 321 10.1055/s-0032-1311827
4. Alarcon-Segovia D., Sanchez-Guerrero J., Primary antiphospholipid syndrome. Journal of Rheumatology 1989 16 4 482 488 2-s2.0-0024308887
5. Harris E. N., Pierangeli S. S., Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name? Seminars in Thrombosis and Hemostasis 2008 34 3 219 226 2-s2.0-50249114024 10.1055/s-0028-1082265
6. Cervera R., Piette J.-C., Font J., Khamashta M. A., Shoenfeld Y., Camps M. T., Jacobsen S., Lakos G., Tincani A., Kontopoulou-Griva I., Galeazzi M., Meroni P. L., Derksen R. H. W. M., De Groot P. G., Gromnica-Ihle E., Baleva M., Mosca M., Bombardieri S., Houssiau F., Gris J.-C., Quéré I., Hachulla E., Vasconcelos C., Roch B., Fernández-Nebro A., Boffa M.-C., Hughes G. R. V., Ingelmo M., Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism 2002 46 4 1019 1027 2-s2.0-0036228886 10.1002/art.10187
7. Vianna J. L., Khamashta M. A., Ordi-Ros J., Font J., Cervera R., Lopez-Soto A., Tolosa C., Franz J., Selva A., Ingelmo M., Vilardell M., Hughes G. R. V., Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. American Journal of Medicine 1994 96 1 3 9 2-s2.0-23444433036 10.1016/0002-9343(94)90108-2
8. Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., Derkesen R. H. W. M., De Groot P. G., Koike T., Meroni P. L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P. G., Krilis S. A., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 2006 4 2 295 306 2-s2.0-33344458573 10.1111/j.1538-7836.2006.01753.x
9. Biggioggero M., Meroni P. L., The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmunity Reviews 2010 9 5 A299 A304 2-s2.0-77649232595 10.1016/j.autrev.2009.11.013
10. Artenjak A., Lakota K., Frank M., Čučnik S., Rozman B., Božič B., Shoenfeld Y., Sodin-Semrl S., Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review. Autoimmunity Reviews 2012 11 12 873 882 2-s2.0-84859492738 10.1016/j.autrev. 2012.03.002
11. Hughes G. R. V., Khamashta M. A., Seronegative antiphospholipid syndrome. Annals of the Rheumatic Diseases 2003 62 12 1127 2-s2.0-0345059323 10.1136/ard.2003.006163
12. Rodriguez-Garcia J. L., Bertolaccini M. L., Cuadrado M. J., Sanna G., Ateka-Barrutia O., Khamashta M. A., Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS'). Annals of the Rheumatic Diseases 2012 71 2 242 244 2-s2.0-84855341072 10.1136/annrheumdis-2011-200614
13. Nayfe R., Uthman I., Aoun J., Aldin S. E., Merashli M., Khamashta M. A., Seronegative antiphospholipid syndrome. Rheumatology 2013 52 8 1358 1367
14. Kaul M., Erkan D., Sammaritano L., Lockshin M. D., Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Annals of the Rheumatic Diseases 2007 66 7 927 930 2-s2.0-34347249882 10.1136/ard.2006.067314
15. Gris J. C., Bouvier S., Antiphospholipid syndrome: looking for a refocusing. Thrombosis Research 2013 131 supplement 1 S28 S31
16. Murthy V., Willis R., Romay-Penabad Z., Ruiz-Limon P., Martinez-Martinez L. A., Jatwani S., Value of isolated IgA anti-beta GPI positivity in the diagnosis of the antiphospholipid syndrome. Arthritis & Rheumatology. In press
17. Petri M., Orbai A. M., Alarcon G. S., Gordon C., Merrill J. T., Fortin P. R., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism 2012 64 8 2677 2686 10.1002/art.34473
18. Mehrani T., Petri M., Association of IgA anti-ß2 glycoprotein i with clinical and laboratory manifestations of systemic lupus erythematosus. Journal of Rheumatology 2011 38 1 64 68 2-s2.0-78650875559 10.3899/jrheum.100568
19. Serrano A., García F., Serrano M., Ramírez E., Alfaro F. J., Lora D., de la Cámara A. G., Paz-Artal E., Praga M., Morales J. M., IgA antibodies against β 2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney International 2012 81 1239 1244 2-s2.0-84857127180 10.1038/ki.2011.477
20. Martinez J. A., Serrano M., Alfaro J., Mora S., Paz-Artal E., Morales J. M., Heterogeneity between diagnostic tests for IgA anti-Beta2 Glycoprotein I would explain the controversy in studies of association with vascular pathology. Analytical Chemistry 2013 85 24 12093 12098 10.1021/ac403194t
21. Lakos G., Favaloro E. J., Harris E. N., Meroni P. L., Tincani A., Wong R. C., Pierangeli S. S., International consensus guidelines on anticardiolipin and anti- β 2-glycoprotein i testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis and Rheumatism 2012 64 1 1 10 2-s2.0-84855294117 10.1002/art.33349
22. Kumar S., Papalardo E., Sunkureddi P., Najam S., González E. B., Pierangeli S. S., Isolated elevation of IgA anti- β 2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients. Lupus 2009 18 11 1011 1014 2-s2.0-70349512004 10.1177/0961203309103048
23. Brandt J. T., Triplett D. A., Alving B., Scharrer I., Criteria for the diagnosis of lupus anticoagulants: an update. Thrombosis and Haemostasis 1995 74 4 1185 1190 2-s2.0-0028810205
24. Andreoli L., Fredi M., Nalli C., Piantoni S., Reggia R., Dall'Ara F., Clinical significance of IgA anti-cardiolipin and IgA anti-beta2glycoprotein I antibodies. Current Rheumatology Reports 2013 15 7 343
25. Tebo A. E., Jaskowski T. D., Hill H. R., Branch D. W., Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss. Clinical and Experimental Immunology 2008 154 3 332 338 2-s2.0-55449123073 10.1111/j.1365-2249.2008.03774.x
26. Mankaï A., Achour A., Thabet Y., Manoubia W., Sakly W., Ghedira I., Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease. Pathologie Biologie 2012 60 5 291 295 2-s2.0-79961141864 10.1016/j.patbio.2011. 07.003
27. Comarmond C., Cacoub P., Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmunity Reviews 2013 12 7 752 757 10.1016/j.autrev.2012.12.006
28. Lopez L. R., Dier K. J., Lopez D., Merrill J. T., Fink C. A., Anti- β 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. American Journal of Clinical Pathology 2004 121 1 142 149 2-s2.0-0345869681 10.1309/YVQ6-PX76- XMYM-3J29
29. Cruz-Tapias P., Blank M., Anaya J. M., Shoenfeld Y., Infections and vaccines in the etiology of antiphospholipid syndrome. Current Opinion in Rheumatology 2012 24 4 389 393
30. Blank M., Israeli E., Shoenfeld Y., When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus 2012 21 7 711 714 10.1177/0961203312438115
31. Salmon J. E., De Groot P. G., Pathogenic role of antiphospholipid antibodies. Lupus 2008 17 5 405 411 2-s2.0-44849103395 10.1177/0961203308090025
32. Takeuchi R., Atsumi T., Ieko M., Amasaki Y., Ichikawa K., Koike T., Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome. British Journal of Haematology 2002 119 3 781 788 2-s2.0-0036433488 10.1046/j.1365-2141.2002.03928.x
33. Meroni P. L., Borghi M. O., Raschi E., Tedesco F., Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nature Reviews Rheumatology 2011 7 6 330 339 2-s2.0-79958086576 10.1038/nrrheum.2011.52
34. Dunoyer-Geindre S., Kruithof E. K. O., Galve-De Rochemonteix B., Rosnoblet C., Gruenberg J., Reber G., De Moerloose P., Localization of β 2-glycoprotein 1 in late endosomes of human endothelial cells. Thrombosis and Haemostasis 2001 85 5 903 907 2-s2.0-0034744188
35. Kornberg A., Renaudineau Y., Blank M., Youinou P., Shoenfeld Y., Anti-beta2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. Israel Medical Association Journal 2000 2 27 31 2-s2.0-0033623763
36. Pierangeli S. S., Harris E. N., Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003 12 7 539 545 2-s2.0-0037700599 10.1191/961203303lu398oa
37. Brandt K. J., Kruithof E. K., de Moerloose P., Receptors involved in cell activation by antiphospholipid antibodies. Thrombosis Research 2013 132 4 408 413
38. Morell A., Skvaril F., Noseda G., Barandun S., Metabolic properties of human IgA subclasses. Clinical and Experimental Immunology 1973 13 4 521 528 2-s2.0-0015609060